Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion)

Atherosclerosis

Volumn 207, Issue 1, 2009, Pages 157-161

  Wada, Masamichi ^a   Iso, Tatsuya ^b   Asztalos, Bela F ^c   Takama, Noriaki ^a   Nakajima, Tadashi ^a   Seta, Yukihiro ^a   Kaneko, Katsumi ^a   Taniguchi, Yasuhiro ^a   Kobayashi, Hideo ^a   Nakajima, Katsuyuki ^c   Schaefer, Ernst J ^c   Kurabayashi, Masahiko ^b  

^a Tomioka General Hospital   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TUFTS UNIVERSITY   (United States)

Author keywords

ApoA I deficiency; Atherosclerosis; HDL deficiency; HDL subpopulations

Indexed keywords

ADENINE; APOLIPOPROTEIN A1; GENOMIC DNA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; CODON; CONTROLLED STUDY; CORNEA OPACITY; CORONARY ARTERY ATHEROSCLEROSIS; DNA SEQUENCE; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; HEART INFARCTION; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; HUMAN CELL; HYPOALPHALIPOPROTEINEMIA; MALE; PRIORITY JOURNAL; VOLUNTEER;

APOLIPOPROTEIN A-I; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CODON; CORNEAL OPACITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DNA MUTATIONAL ANALYSIS; DOWN-REGULATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FRAMESHIFT MUTATION; GENETIC PREDISPOSITION TO DISEASE; HEART ANEURYSM; HETEROZYGOTE; HOMOZYGOTE; HUMANS; HYPOLIPOPROTEINEMIAS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEDIGREE; PHENOTYPE; SEQUENCE DELETION; SEVERITY OF ILLNESS INDEX; TRIGLYCERIDES;

EID: 70350575335     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.04.018     Document Type: Article

References (16)

1. Gotto Jr. A.M., and Brinton E.A. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update. J Am Coll Cardiol 43 (2004) 717-724
2. Oram J.F., and Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res 37 (1996) 2473-2491
3. Mackness M.I., Durrington P.N., and Mackness B. How high-density lipoprotein protects against the effects of lipid peroxidation. Curr Opin Lipidol 11 (2000) 383-388
4. Brooks-Wilson A., Marcil M., Clee S.M., et al. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat Genet 22 (1999) 336-345
5. Kuivenhoven J.A., Pritchard H., Hill J., Frohlich J., Assmann G., and Kastelein J. The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. J Lipid Res 38 (1997) 191-205
6. Sorci-Thomas M.G., and Thomas M.J. The effects of altered apolipoprotein A-I structure on plasma HDL concentration. Trends Cardiovasc Med 12 (2002) 121-128
7. Zannis V.I., Chroni A., and Krieger M. Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med 84 (2006) 276-294
8. Frank P.G., and Marcel Y.L. Apolipoprotein A-I: structure-function relationships. J Lipid Res 41 (2000) 853-872
9. Santos R.D., Schaefer E.J., Asztalos B.F., et al. Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency. J Lipid Res 49 (2008) 349-357
10. von Eckardstein A. Differential diagnosis of familial high density lipoprotein deficiency syndromes. Atherosclerosis 186 (2006) 231-239
11. Asztalos B.F., Schaefer E.J., Horvath K.V., et al. Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res 48 (2007) 592-599
12. Chroni A., Liu T., Fitzgerald M.L., Freeman M.W., and Zannis V.I. Cross-linking and lipid efflux properties of apoA-I mutants suggest direct association between apoA-I helices and ABCA1. Biochemistry 43 (2004) 2126-2139
13. Chroni A., Liu T., Gorshkova I., et al. The central helices of ApoA-I can promote ATP-binding cassette transporter A1 (ABCA1)-mediated lipid efflux. Amino acid residues 220-231 of the wild-type ApoA-I are required for lipid efflux in vitro and high density lipoprotein formation in vivo. J Biol Chem 278 (2003) 6719-6730
14. Wang N., Silver D.L., Costet P., and Tall A.R. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 275 (2000) 33053-33058
15. Dastani Z., Dangoisse C., Boucher B., et al. A novel nonsense apolipoprotein A-I mutation (apoA-I(E136X)) causes low HDL cholesterol in French Canadians. Atherosclerosis 185 (2006) 127-136
16. Ikewaki K., Matsunaga A., Han H., et al. A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease. Atherosclerosis 172 (2004) 39-45